Atlas Trials

CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

Clinical trial NCT04734873 · TERMINATED

Trial details

NCT number
NCT04734873
Sponsor
Corvus Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid-19
Start date
2021-02-25
Primary completion
2021-08-18
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.